Class information for:
Level 1: APNEA OF PREMATURITY//DOXAPRAM//RESPIRATORY STIMULANTS

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
16727 574 28.0 51%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
1062 9507 CAFFEINE//COFFEE//ENERGY DRINKS

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 APNEA OF PREMATURITY Author keyword 16 44% 5% 28
2 DOXAPRAM Author keyword 13 43% 4% 23
3 RESPIRATORY STIMULANTS Author keyword 4 67% 1% 4
4 CAFFEINE CITRATE Author keyword 4 75% 1% 3
5 CAFFEINE THERAPEUTIC USE Author keyword 3 100% 1% 3
6 XANTHINES THERAPEUTIC USE Author keyword 3 100% 1% 3
7 APNOEA OF PREMATURITY Author keyword 3 40% 1% 6
8 CENTRAL NERVOUS SYSTEM STIMULANTS THERAPEUTIC USE Author keyword 3 60% 1% 3
9 RESPIRATORY STIMULANT Author keyword 3 60% 1% 3
10 DOXAPRAM HYDROCHLORIDE Author keyword 2 67% 0% 2

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 APNEA OF PREMATURITY 16 44% 5% 28 Search APNEA+OF+PREMATURITY Search APNEA+OF+PREMATURITY
2 DOXAPRAM 13 43% 4% 23 Search DOXAPRAM Search DOXAPRAM
3 RESPIRATORY STIMULANTS 4 67% 1% 4 Search RESPIRATORY+STIMULANTS Search RESPIRATORY+STIMULANTS
4 CAFFEINE CITRATE 4 75% 1% 3 Search CAFFEINE+CITRATE Search CAFFEINE+CITRATE
5 CAFFEINE THERAPEUTIC USE 3 100% 1% 3 Search CAFFEINE++THERAPEUTIC+USE Search CAFFEINE++THERAPEUTIC+USE
6 XANTHINES THERAPEUTIC USE 3 100% 1% 3 Search XANTHINES+THERAPEUTIC+USE Search XANTHINES+THERAPEUTIC+USE
7 APNOEA OF PREMATURITY 3 40% 1% 6 Search APNOEA+OF+PREMATURITY Search APNOEA+OF+PREMATURITY
8 CENTRAL NERVOUS SYSTEM STIMULANTS THERAPEUTIC USE 3 60% 1% 3 Search CENTRAL+NERVOUS+SYSTEM+STIMULANTS+THERAPEUTIC+USE Search CENTRAL+NERVOUS+SYSTEM+STIMULANTS+THERAPEUTIC+USE
9 RESPIRATORY STIMULANT 3 60% 1% 3 Search RESPIRATORY+STIMULANT Search RESPIRATORY+STIMULANT
10 DOXAPRAM HYDROCHLORIDE 2 67% 0% 2 Search DOXAPRAM+HYDROCHLORIDE Search DOXAPRAM+HYDROCHLORIDE

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 IDIOPATHIC APNEA 76 85% 7% 40
2 NEONATAL APNEA 14 64% 2% 14
3 CAFFEINE THERAPY 6 34% 2% 14
4 LOW DOSE DOXAPRAM 6 100% 1% 4
5 METHYLXANTHINE THERAPY 3 100% 1% 3
6 DOXAPRAM 3 26% 2% 10
7 CAFFEINE CITRATE 2 67% 0% 2
8 CHEMODENERVATED LAMBS 1 100% 0% 2
9 HYPEROXIC TEST 1 50% 0% 2
10 OBSTRUCTIVE APNEA 1 22% 1% 5

Journals

Reviews


Title Publ. year Cit. Active
references		 % act. ref.
to same field
Prophylactic methylxanthines for endotracheal extubation in preterm infants 2010 10 9 100%
Methylxanthine treatment for apnoea in preterm infants 2010 11 11 91%
Caffeine impact on neonatal morbidities 2010 14 18 78%
Caffeine versus theophylline for apnea in preterm infants 2010 6 11 82%
Caffeine citrate: when and for how long. A literature review 2012 2 19 89%
Apnea of prematurity: from cause to treatment 2011 29 70 33%
Prophylactic methylxanthine for prevention of apnoea in preterm infants 2010 3 10 80%
Evidence behind the WHO guidelines: Hospital care for children: Is caffeine useful in the prevention of apnoea of prematurity? 2007 2 2 100%
Interventions for apnoea of prematurity: a personal view 2010 10 40 48%
Use of Methylxanthine Therapies for the Treatment and Prevention of Apnea of Prematurity 2014 0 51 73%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 10240 KINGSWAY AVE 1 100% 0.3% 2
2 FILDERKLIN 1 100% 0.3% 2
3 QUEEN ELIZABETH II 1 24% 0.7% 4
4 CHILDHOOD ADOLESCENCE MED 1 50% 0.2% 1
5 COMERS CHILDREN HOSP 1 50% 0.2% 1
6 GEN PEDIAT ADOLESCENT MED NEONATOL 1 50% 0.2% 1
7 HIGH RISK NEONATAL 1 50% 0.2% 1
8 HOP LE PARC 1 50% 0.2% 1
9 MCP HAHNEMANN MED PEDIAT 1 50% 0.2% 1
10 MED NEW YORK HOSP PHARMACOL 1 50% 0.2% 1

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000229194 LARYNGEAL CHEMOREFLEX//GLOTTIC CLOSURE REFLEX//LARYNGEAL SPHINCTER
2 0.0000179072 PERINATAL NUTR METAB//SECT DEV ENDOCRINOL BIOLYALE CHILD HLTH CT//XENOBIOTIC AGENTS
3 0.0000122302 CAS 58 55 9//ABT BIOPHARM PHARMAKOKINETIK//BRONCHORETARD R
4 0.0000120084 HIGH FLOW NASAL CANNULA//BUBBLE CPAP//INSURE
5 0.0000117347 SUDDEN INFANT DEATH SYNDROME//SIDS//SUDDEN INFANT DEATH
6 0.0000096040 PATIENT TRIGGERED VENTILATION//VOLUME GUARANTEE//VOLUME TARGETED VENTILATION
7 0.0000075761 ALMITRINE//ALMITRINE BISMESYLATE//DRUG INDUCED LIPIDOSIS
8 0.0000073129 UNLICENSED//OFF LABEL//OFF LABEL DRUG USE
9 0.0000071262 FETAL NEONATAL MED//NEONATAL BLOOD PRESSURE//TRANSCEPHALIC ELECTRICAL IMPEDANCE
10 0.0000069045 CYP1A2//CAFFEINE METABOLISM//CYP1A2 ACTIVITY